Clinical Trial Update: Trial of Microplasmin Intravitreal Injection for Non-surgical Treatment of Focal Vitreomacular Adhesion. The MIVI-TRUST (TG-MV-006) Trial. [Phase 3]

View source ↗

Summary

Phase 3 trial results for intravitreal microplasmin (MIVI-TRUST, TG-MV-006) evaluating non-surgical treatment of focal vitreomacular adhesion have been complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitreomacular Adhesion

Drugs mentioned

• microplasmin (microplasmin)

Snippet

Sponsor: ThromboGenics | Conditions: Vitreomacular Adhesion | Phase 3 | Status: COMPLETED | Results posted: 2013-01-28